Authors: Kissling, E., Valenciano, M., Pozo, F., Vilcu, A.-., Reuss, A., Rizzo, C., Larrauri, Horvath, J.K., Brytting, Domegan, L., Korczynska, Meijer, Machado, Ivanciuc, Visekruna Vucina, V., van der Werf, S., Schweiger, B., Bella, Gherasim, Ferenczi, Zakikhany, K., O'Donnell, J., Paradowska-Stankiewicz, I., Dijkstra, Guiomar, R., Lazar, Kurecic Filipovic, Johansen, Moren, I-MOVE/I-MOVE+ study team, Pariani

Venue: Influenza and Other Respiratory Viruses

Type: Publication

Abstract: BACKGROUND: During the 2015/16 influenza season in Europe, the cocirculating influenza viruses were A(H1N1)pdm09 and B/Victoria, which was antigenically distinct from the B/Yamagata component in the trivalent influenza vaccine. METHODS: We used the test-negative design in a multicentre case-control study in twelve European countries to measure 2015/16 influenza vaccine effectiveness (VE) against medically attended influenza-like illness (ILI) laboratory-confirmed as influenza. General practitioners swabbed a systematic sample of consulting ILI ... (read more)

DOI: 10.25646/6054 (Found 2 versions)